Filing Details
- Accession Number:
- 0001104659-24-119844
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-15 21:30:49
- Reporting Period:
- 2024-11-14
- Accepted Time:
- 2024-11-15 21:30:49
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1689548 | Praxis Precision Medicines Inc. | PRAX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1827760 | Alex Nemiroff | C/O Praxis Precision Medicines, Inc. 99 High Street, 30Th Floor Boston MA 02110 | General Counsel And Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-11-14 | 7,583 | $56.94 | 18,540 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-11-14 | 8,239 | $80.20 | 10,301 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2024-11-14 | 7,583 | $0.00 | 7,583 | $56.94 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
28,817 | 2034-07-29 | No | 4 | M | Direct |
Footnotes
- The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $80.12 to $80.21. The Reporting Person undertakes to provide upon request from the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
- The shares underlying this stock option vested as to 7/48ths on July 29, 2024 and the remaining shares vest in substantially equal monthly installments over the following 41 months, subject to the reporting person's continued service through each vesting date.